We serve Chemical Name:5-pyridin-3-yloxyfuran-2-carboxylic acid CAS:852180-39-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-pyridin-3-yloxyfuran-2-carboxylic acid
CAS.NO:852180-39-3
Synonyms:5-pyridin-3-yloxyfuran-2-carboxylic acid
Molecular Formula:C10H7NO4
Molecular Weight:205.16700
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:386.5ºC at 760 mmHg
Density:1.38g/cm3
Index of Refraction:1.588
PSA:72.56000
Exact Mass:205.03800
LogP:2.16510
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-pyridin-3-yloxyfuran-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-pyridin-3-yloxyfuran-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-pyridin-3-yloxyfuran-2-carboxylic acid Use and application,5-pyridin-3-yloxyfuran-2-carboxylic acid technical grade,usp/ep/jp grade.
Related News: Denise Bowser, commercial director at Onyx, commented, “Over the years, we have worked towards building a strong reputation in helping drug developers with complex chemistry. 2-Ethyl-2-cyano-4-pentenoyl Chloride manufacturers Denise Bowser, commercial director at Onyx, commented, “Over the years, we have worked towards building a strong reputation in helping drug developers with complex chemistry. Dehydrogenase, reduced nicotinamide adenine dinucleotide(Thylacomys lagotis mitochondria-encoded gene ND1 subunit 1) suppliers Aduhelm was approved by the Food and Drug Administration on June 7. The drug, scientifically known as aducanumab, offers new hope to friends and families of patients living with the disease and is expected to generate billions of dollars in revenue for the company. 3-(5,6-dimethoxy-2,3-dihydro-indol-1-yl)-inden-1-one vendor & factory CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. ,Aduhelm was approved by the Food and Drug Administration on June 7. The drug, scientifically known as aducanumab, offers new hope to friends and families of patients living with the disease and is expected to generate billions of dollars in revenue for the company.
